Avidity Partners Management’s Orchestra BioMed OBIO Stock Holding History

Avidity Partners Management’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400,000	Closed	-$3.99M	–	91
2022 Q4	$3.99M	Hold	400,000	–	–	0.09%	71
2022 Q3	$3.96M	Hold	400,000	–	–	0.09%	83
2022 Q2	$3.98M	Hold	400,000	–	–	0.09%	65
2022 Q1	$3.96M	Hold	400,000	–	–	0.09%	78
2021 Q4	$4.03M	Hold	400,000	–	–	0.09%	84
2021 Q3	$3.96M	Hold	400,000	–	–	0.1%	90
2021 Q2	$4.08M	Hold	400,000	–	–	0.11%	99
2021 Q1	$4.48M	Hold	400,000	–	–	0.12%	85
2020 Q4	$5.12M	Hold	400,000	–	–	0.17%	79
2020 Q3	$4.4M	Buy	+400,000	New	+$4.49M	0.24%	59

Other funds holding OBIO

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

SVB Financial Group Dallas, Texas $434K AUM 277.67% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return